News
Detailed price information for Passage Bio Inc (PASG-Q) from The Globe and Mail including charting and trades.
9d
MyChesCo on MSNPassage Bio Reports Progress in Gene Therapy for Frontotemporal DementiaPHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) has announced encouraging updates from the ongoing Phase 1/2 upliFT-D ...
Detailed price information for Passage Bio Inc (PASG-Q) from The Globe and Mail including charting and trades.
Acclaimed British actress and filmmaker Theresa Godly is earning international attention with her powerful short film, The Stranger I Love, inspired by her own harrowing experience with parental ...
In a turbulent market environment, Passage Bio Inc (PASG) stock has reached a new 52-week low, dipping to $0.3. With a market capitalization of just $19.33 million and a beta of 1.59 indicating ...
Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...
Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Passage Bio Inc (PASG) stock has hit a 52-week low, trading at $0.55, as the company faces ongoing market headwinds. This latest price level reflects a significant downturn for the biotechnology ...
Hosted on MSN10mon
Rodman & Renshaw Initiates Coverage of Passage Bio (PASG) with Buy Recommendation - MSNFintel reports that on September 3, 2024, Rodman & Renshaw initiated coverage of Passage Bio (NasdaqGS:PASG) with a Buy recommendation. Analyst Price Forecast Suggests 940.03% Upside As of August ...
Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results